R1: Tris buffer pH 7.8 100 mmol/l L-Aspartate 200 mmol/l LDH 800 U/l MDH 600 U/l R2: NADH2 0.18 mmol/l 2-Oxoglutarate 12 mmol/l

許可證數量: 1

CEFTRIAXONE (DISODIUM 3.5H2O)

許可證數量: 16

Oxolamine citrate contains not less than 99.0% and not more than 101.0% of C14H19N3O.C6H8O7, calculated with reference to the dried substance.

許可證數量: 1

R1 Imidazole: 58.0 mmol/L, pH: 6.00; N-acetylcysteine: 40.0 mmol/L; EDTA: 3.00 mmol/L; AMP: 10.0 mmol/L; diadenosine pentaphosphate: 24.0 μmol/L; NADP+: 9.5 mmol/L; Mg2+: 20.0 mmol/L; D-glucose: 40.0 mmol/L; stabilizer.

許可證數量: 1

R1: TRIS buffer: 264 mmol/L, pH 8.1; L-aspartate: 792 mmol/L; MDH (microorganism):≧24 μkat/L; LDH (microorganisms): ≧48 μkat/L; albumin (bovine): 0.25%; preservative R2: Pyridoxal phosphate: 730 μmol/L; preservative R3: NADH

許可證數量: 1

SR EDTA: 3.00 mmol/L, pH: 9.1; HK (yeast):≧600 μkat/L; G6P-DH (microbial): ≧600 μkat/L; ADP: 12.0 mmol/L; creatine phosphate: 180 mmol/L; N-methyldiethanolamine: 69.0 mmol/L; monoclonal murine antibodies inhibiting human CK-M

許可證數量: 1

SR: NADH (yeast): ≧1.7 mmol/L; 2-oxoglutarate: 94 mmol/L; preservative; additives

許可證數量: 1

R1 2-Amino-2-methyl-1-propanol: 1.724 mol/L, pH 10.5 (30 ℃); magnesium acetate: 3.83 mmol/L; zinc sulfate: 0.766 mmol/L; N-(2-hydroxyethyl)-ethylenediamine triacetic acid: 3.83 mmol/L SR p-nitrophenyl phosphate: 132.8 mmol/L,

許可證數量: 1

R1 Phosphoenolpyruvate: >60 mmol/L; NADH analog: 3 mmol/L; MDH (porcine):≧1200 nkat/L; PEPC (microbial):≧120 nkat/L

許可證數量: 1

R1 Sulfanilic acid: 35 mmol/L; HEDTA: 4.0 mmol/L; oxalic acid: 40 mmol/L; pH 1.2 R2 Sodium nitrite: 3.9 mmol/L; pH 6.0

許可證數量: 1

NORFLOXACIN (BACCIDAL)

許可證數量: 48

AMMONIA (30%)

許可證數量: 21

1.試片試劑之組成：Glucose Oxidase (Aspergillus Niger)：8%, Potassium ferricyanide：56.6%, Non-reactive ingredients：35.4% 2.品管液之組成：Water 84%, Glucose 0.1%, Thickening agent 15%, Inorganic salt/buffer 1.0%, Dye 0.08%, Bacteriostat 0.03%

許可證數量: 1

Hyaluronic acid, Stabilized 20mg Phys. Sodium chloride solution, pH7 q.s.。變更處方Hyaluronic acid, Stabilized 20mgPhosphate buffered saline q.s.。

許可證數量: 1

1.Goat anti-mouse-IgG(14%) 2.Benzoylecgonine-BSA(20%) 3.Mab anti-Benzoylecgonine CGC(23%)

許可證數量: 1

Bisoprolol Fumarate cotnains not less than 97.5% and not more than 102.0% of (C18H91NO4)2˙C4H4O4, calculated on the anhydrous basis.

許可證數量: 1

DF114：particle reagent 2mg/ml, NaOH 0.5N, antibody to human albumin 140 μg/ml, buffer DC114：Human albumin 0, 12.5, 25, 50, 110 mg/L

許可證數量: 1

Levonorgestrel contains not less than 98.0% and not more than the equivalent of 102.0% of C21H28O2, calculated with reference to the dried substance.

許可證數量: 1

sodium nitroprusside 116 μg, 2,6-dichlorophenolindophenol 7.5 μg, glucose oxidase 3.2 U, peroxidase 0.2 U, o-tolidine 65 μg

許可證數量: 1

tetrabromophenol blue 7.5 μg, 2,6-dichlorophenolindophenol 7.5 μg, glucose oxidase 3.2 U, peroxidase 0.2 U, o-tolidine 65 μg, methyl red 2.8 μg, bromothymol blue 10 μg

許可證數量: 1

Tetramethylbenzidine 59 μg, cumene hydroperoxide 253 μg, diazonium salt 28 μg, diazonium salt 26 μg, tetrabromophenol blue 7.5 μg, sulfanilic acid 80 μg, quinoline derivative 25 μg, sodium nitroprusside 116 μg, 2,6-dichloroph

許可證數量: 1

tetramethylbenzidine 59 μg, cumene hydroperoxide 253 μg, diazonium salt 28 μg, diazonium salt 26 μg, tetrabromophenol blue 7.5 μg, sulfanilic acid 80 μg, quinoline derivative 25 μg, sodium nitroprusside 116 μg, glucose oxidas

許可證數量: 1

The matrix for the UTAK Tri-Level Immunosuppressants Control is prepared from normal human whole blood. The analytes are added and adjusted to the desired concentration range for each lot prepared.

許可證數量: 1

0.025 mg Sodium citrate, 0.013 mg Gold chloride, 0.2 μg Mouse anti β-HCG, 0.12 μg Mouse IgG, 0.6 μg Goat anti mouse IgG, 0.6 μg Goat anti α-HCG, 9 mg Sodium chloride, 0.278 mg Sodium phosphate, Monobasic Crystal, 1.38 mg Sodi

許可證數量: 2

Fenofibrate contains not less than 98.5% and not more than 101.0% of C20H21ClO4 calculated with reference to the dried substance.

許可證數量: 1

Metaxalone contains not less than 98.0 percent and not more than 102.0 percent of C12H15NO3

許可證數量: 1

Ramipril contains not less than 98.0% and not more than 101.0% of C23H32N2O5, calculated with reference to the dried substance.

許可證數量: 1

Cal1 Negative calibrator 1, 2 bottles of 1.0 mL each: Human serum, non-reactive for anti-Rubella IgG; preservative. Cal2 Positive calibrator 2, 2 bottles of 1.0 mL each: Anti-Rubella IgG approx. 400 IU/mL in human serum; pres

許可證數量: 1

PreciControl ？PC RUBIGG1: 8 bottles, each containing 1.0 mL of control serum Human serum, negative to low positive for Rubella IgG antibodies (approx. 4 IU/mL); preservative. ？PC RUBIGG2: 8 bottles, each containing 1.0 mL of

許可證數量: 1

R1 HEPES: 52.4 mmol/L; Sodium chloride: 87 mmol/L; Calcium chloride: 0.08 mmol/L; Magnesium chloride: 12.6 mmol/L; α-Glucosidase (microbial): ≥66.8 μkat/L; pH 7.0 (37°C); preservatives; stabilizers SR HEPES: 52.4 mmol/L

許可證數量: 1

R1: TAPS buffer (N-Tris(hydroxymethyl)methyl-3-aminopropanesulfonic acid): 30 mmol/L, pH 8.1; creatinase (microorganisms):≧332 μkat/L; sarcosine oxidase (microorganisms):):≧132 μkat/L; ascorbate oxidase (microorganisms):≧33 μ

許可證數量: 1

R1: TRIS buffer with bovine serum albumin and immunoglobulins (mouse); preservative. SR: Latex particles coated with anti-CRP (mouse) in glycine buffer; preservative.

許可證數量: 1

Reagent - M Streptavidin-coated microparticles, 1 bottle, 6.5 mL: Streptavidin-coated microparticles 0.72 mg/mL; preservative. R1 Anti-h IgG-Ab~biotin, 1 bottle, 10 mL: Biotinylated monoclonal anti-h IgG antibody (mouse), RLP

許可證數量: 1

SR: TAPS buffer: 50 mmol/L, pH 8.0; creatininase (microorganisms):≧498 μkat/L; peroxidase (horseradish): ≧16.6 μkat/L; 4-aminophenazone: 0.5 g/L; potassium hexacyanoferrate (II): 60 mg/L; detergent; preservative

許可證數量: 1

DASATINIB

許可證數量: 3

Ciprofloxacin Hydrochloride contains not less than 98.0% and not more than 102.0% of C17H18FN3O3.HCl, calculated on the anhydrous basis.

許可證數量: 2

Elecsys PreciControl Rubella IgM PC RUBIGM1: 4 bottles, each containing 1.0 mL of control serum Human serum, negative for Rubella IgM antibodies; preservative. PC RUBIGM2: 4 bottles, each containing 1.0 mL of control serum Hu

許可證數量: 1

Elecsys Rubella IgM M: Streptavidin-coated microparticles (transparent cap), 1 bottle, 6.5 mL: Streptavidin-coated microparticles 0.72 mg/mL; preservative. R1: Anti-h IgM-Ab~biotin; Rubella-specific recombinant antigen (gray

許可證數量: 1

R1:HEPES buffer: 52.4 mmol/L, pH 7.1; sodium chloride: 87 mmol/L; magnesium chloride: 12.6 mmol/L; calcium chloride: 0.075 mmol/L; α-glucosidase (microbial): ≧67 μkat/L; monoclonal antibodies (mouse): 95 μg/L; preservatives

許可證數量: 1

SR:HEPES buffer: 52.4 mmol/L, pH 7.1; 4,6-ethylidene-G7PNP: 22 mmol/L; preservatives; stabilizers

許可證數量: 1

CalSet ？ACTH Cal1: 2 bottles, each for 1.0 mL of calibrator 1 ？ACTH Cal2: 2 bottles, each for 1.0 mL of calibrator 2 ACTH (synthetic) in two concentration ranges (approx. 15 pg/mL and approx. 120 pg/mL) in an equine serum mat

許可證數量: 1

Control Solution contains： Control solution level G1 G2 Glucose 0.05 0.15 Buffer 0.81 0.81 Preservative 0.30 0.30 Other constituents 18.00 18.00 Water 80.84 80.74

許可證數量: 1

PreciControl ACTH ？PC ACTH1: 2 bottles, each for 2.0 mL of control serum ？PC ACTH2: 2 bottles, each for 2.0 mL of control serum ACTH (synthetic) in two concentration ranges (approx. 100pg/mL and approx. 1000 pg/mL) in an equi

許可證數量: 1

R1 Imidazole: 58.0 mmol/L, pH 6.00; N-acetylcysteine: 40.0 mmol/L; EDTA: 3.00 mmol/L; AMP: 10.0 mmol/L; diadenosine pentaphosphate: 24.0μmol/L; NADP+: 9.5 mmol/L; Mg2+: 20.0 mmol/L; D-glucose: 40.0 mmol/L; preservative; stabi

許可證數量: 1

Reagent kit M Streptavidin-coated microparticles, 1 bottle, 6.5mL: Steptavidin-coated microparticles, 0.72 mg/mL, binding capacity: 470 ng biotin/mg microopaticles, preservative. R1 Anti-ACTH-Ab~biotin, 1 bottle, 8 mL: Biotin

許可證數量: 1

SR EDTA: 3.00 mmol/L, pH 9.1; HK (yeast): ≧600μkat/L; G6P-DH (microbial): ≧600μkat/L; ADP:12.0 mmol/L; creatine phosphate: 180 mmol/L; N-methyldiethanolamine : 69.0 mmol/L; preservative; stabilizer; detergent.

許可證數量: 1

Sodium copper chlorophyllin contains not less than 98% (on the dried basis).

許可證數量: 1

Chlorpromazine Hydrochloride contains not less than 98.0% and not more than 101.5% of C17H19ClN2S HCl, calculated on the dried basis.

許可證數量: 1

Fluoxetine Hydrochloride contains not less than 98.0% and not more than 101.5% of C17H18F3NO？HCl, calculated on the dried basis.

許可證數量: 1

N CDT Reagent 1 (3 × 0.9 mL) consists of a suspension of polystyrene particles coated with carbohydrate-deficient transferrin (< 0.017 g/L). N CDT Reagent 2 (3 × 0.9 mL) consists of a suspension of polystyrene particles coate

許可證數量: 1